We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transplanted Muscle Cells May Aid Damaged Hearts

By Biotechdaily staff writers
Posted on 28 Nov 2002
A study in which muscle cells were transplanted from the thighs of heart patients into their damaged hearts shows evidence of skeletal muscle cell survival and differentiation into mature muscle fibers, leading perhaps to a way to repair damaged hearts without rejection. More...
The results were presented at the 2002 Scientific Sessions of the American Heart Association in Chicago, IL (USA).

Three patients had cells from their thigh muscles injected into their heart muscle while they awaited a heart transplant, then allowed their old, damaged hearts to be examined for signs of cell growth after they received a new heart. Examination revealed that the injected cells not only survived but also began to form muscle fiber. In addition, the areas where the cells were injected showed an increase in the formation of small blood vessels. Since the muscle cells came from the patients' own bodies, none of the patients experienced an immune reaction to the transplants.

The study is based on the premise that certain kinds of cells can be expanded in culture and maintain their functional characteristics. Instead of stem cells, the study used satellite cells, which occur naturally in muscle and help repair damage by dividing and moving to injured areas. After removing cells from the quadriceps muscle, researchers treated them with enzymes to isolate the satellite cells. These were then grown in a laboratory under carefully controlled conditions to give the cells time to divide and produce 300 million cells.

One arm of the study was conducted at the University of Michigan Health System (U-M, Ann Arbor, USA) and Temple University (Chattanooga, TN, USA). This arm involved patients awaiting a heart transplant or a left ventricular assist device (LVAD). Another arm of the study, conducted at the Arizona Heart Institute (Phoenix, USA; www.azheart.com), examined how well patients tolerated different doses of transplanted muscles cells during heart bypass surgery. Indirect evidence of scar tissue regeneration was noted in these patients.

"These results give us the first indication that muscle cell transplants, even from an entirely different kind of muscle, could one day be used to help repair damaged, failing hearts without danger of rejection,” said Francis Pagani, M.D., Ph.D., head of the heart transplant program at the U-M Cardiovascular Center.




Related Links:
Univ. of Michigan
Temple Univ

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Drug Testing Assays
Atellica DT 250 Analyzer
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.